A real-world study of Oregon's nonmedical psilocybin program shows promise
August 19, 2026
The first multisite study of psychedelics outside of a clinical trial suggests psilocybin services in Oregon relieve symptoms of anxiety, depression and PTSD. Todd Korthuis, M.D., says, “Safety was very similar to what we’ve seen with psychedelics in clinical settings. That’s important because there was a big question around whether or not safety in carefully controlled psilocybin clinical trial would translate into real-world use."